Agreement to strengthen MBS review process and informed financial consent
The Federal Government and the Australian Medical Association (AMA) have agreed to co-design administrative processes for implementing upcoming changes to ...
The Federal Government and the Australian Medical Association (AMA) have agreed to co-design administrative processes for implementing upcoming changes to ...
Nova Eye Medical has announced an application to secure public funding for its iTrack ab-interno canaloplasty as a standalone minimally ...
The head of ophthalmic surgery at a major public hospital says the current Medicare fee for intravitreal injections only creates ...
Despite vehement opposition from ophthalmologists, the MBS Taskforce has forged ahead with plans to cut the rebate for intravitreal injections ...
Optometry Australia (OA) is working with a group of optometrists with expertise in telehealth to develop evidence-based advice on appropriate ...
Medicare fees for all optometry items have increased 1.5% this month as part of reintroduced annual indexation, however advocates warn ...
Telehealth Medicare items will be expanded to encompass allied health professionals, such as optometrists, by Monday as the Federal Government ...
New figures have revealed Australian optometrists performed a record number of Medicare consultations last year, while children’s vision assessments increased ...
Proposed cuts to the rebate and fee for intravitreal injections will impact bulk billing services and access to treatment, Australia’s ...
Government advisors have recommended minimally invasive glaucoma surgery (MIGS) should be publicly funded as a standalone procedure, following extensive campaigning ...
Insight has been the leading industry publication in Australia for more than 40 years. This longevity is largely due to our ability to consistently deliver accurate and independent news relevant to all ophthalmic professionals and their supporting industry.
© 2025 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited
© 2025 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited